Dr. Samantha Morris received her undergraduate degree in Biochemistry from Imperial College of Science, Technology and Medicine, the University of London, UK. She earned her PhD from the University of Cambridge, focusing on endoderm fate specification in Xenopus laevis development. Dr. Morris remained in Cambridge as a Research Fellow, joining the laboratory of Magdalena Zernicka-Goetz (Gurdon Institute, Cambridge) to investigator early mammalian fate specification. Her work on early cell fate plasticity spurred interest in manipulating cell fate for therapeutic purposes. In pursuit of this Samantha has joined the laboratory of George Daley at Boston Children’s Hospital and Harvard Medical School, where she focused on analysis of gene regulatory networks to dissect and engineer cell fate. She joined Washington University in 2015.